Literature DB >> 26568914

Hepatitis delta virus: A fascinating and neglected pathogen.

Celso Cunha1, João Paulo Tavanez1, Severin Gudima1.   

Abstract

Hepatitis delta virus (HDV) is the etiologic agent of the most severe form of virus hepatitis in humans. Sharing some structural and functional properties with plant viroids, the HDV RNA contains a single open reading frame coding for the only virus protein, the Delta antigen. A number of unique features, including ribozyme activity, RNA editing, rolling-circle RNA replication, and redirection for a RNA template of host DNA-dependent RNA polymerase II, make this small pathogen an excellent model to study virus-cell interactions and RNA biology. Treatment options for chronic hepatitis Delta are scarce and ineffective. The disease burden is perhaps largely underestimated making the search for new, specific drugs, targets, and treatment strategies an important public health challenge. In this review we address the main features of virus structure, replication, and interaction with the host. Virus pathogenicity and current treatment options are discussed in the light of recent developments.

Entities:  

Keywords:  Hepatitis B virus; Hepatitis delta virus; Pathogenesis; RNA replication; Treatment

Year:  2015        PMID: 26568914      PMCID: PMC4641224          DOI: 10.5501/wjv.v4.i4.313

Source DB:  PubMed          Journal:  World J Virol        ISSN: 2220-3249


  115 in total

1.  Two-year interferon therapy with or without ribavirin in chronic delta hepatitis.

Authors:  Fulya Gunsar; Ulus Salih Akarca; Galip Ersoz; Arzu Celebi Kobak; Zeki Karasu; Gul Yuce; Tankut Ilter; Yucel Batur
Journal:  Antivir Ther       Date:  2005

2.  Intrinsic disorder and oligomerization of the hepatitis delta virus antigen.

Authors:  Carolina Alves; Hong Cheng; Heinrich Roder; John Taylor
Journal:  Virology       Date:  2010-09-19       Impact factor: 3.616

3.  Hepatitis delta: on soft paws across Germany.

Authors:  C Reinheimer; H W Doerr; A Berger
Journal:  Infection       Date:  2012-07-01       Impact factor: 3.553

4.  Assembly of hepatitis delta virus particles.

Authors:  W S Ryu; M Bayer; J Taylor
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  Multimerization of hepatitis delta antigen is a critical determinant of RNA binding specificity.

Authors:  Brian C Lin; Dawn A Defenbaugh; John L Casey
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

6.  Characterization of nuclear targeting signal of hepatitis delta antigen: nuclear transport as a protein complex.

Authors:  Y P Xia; C T Yeh; J H Ou; M M Lai
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  Hepatitis delta virus infects the cells of hepadnavirus-induced hepatocellular carcinoma in woodchucks.

Authors:  Natalia Freitas; Jessica Salisse; Celso Cunha; Ilia Toshkov; Stephan Menne; Severin O Gudima
Journal:  Hepatology       Date:  2012-04-25       Impact factor: 17.425

8.  Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1.

Authors:  Swee Kee Wong; David W Lazinski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-24       Impact factor: 11.205

9.  The double-stranded RNA-activated kinase, PKR, can phosphorylate hepatitis D virus small delta antigen at functional serine and threonine residues.

Authors:  Chi-Wu Chen; Yeou-Guang Tsay; Hui-Lin Wu; Chi-Hua Lee; Ding-Shinn Chen; Pei-Jer Chen
Journal:  J Biol Chem       Date:  2002-06-11       Impact factor: 5.157

10.  Entecavir treatment of chronic hepatitis D.

Authors:  Gökhan Kabaçam; F Oguz Onder; Mustafa Yakut; Gülseren Seven; Senem C Karatayli; Ersin Karatayli; Berna Savas; Ramazan Idilman; A Mithat Bozdayi; Cihan Yurdaydin
Journal:  Clin Infect Dis       Date:  2012-05-09       Impact factor: 9.079

View more
  7 in total

Review 1.  Mode and tempo of human hepatitis virus evolution.

Authors:  Rachele Cagliani; Diego Forni; Manuela Sironi
Journal:  Comput Struct Biotechnol J       Date:  2019-10-25       Impact factor: 7.271

Review 2.  Evolutionary biology of human hepatitis viruses.

Authors:  Andrea Rasche; Anna-Lena Sander; Victor Max Corman; Jan Felix Drexler
Journal:  J Hepatol       Date:  2018-11-23       Impact factor: 25.083

3.  Stage of disease in hepatitis B virus infection in Zambian adults is associated with large cell change but not well defined using classic biomarkers.

Authors:  Bright Nsokolo; Anne Kanunga; Edford Sinkala; Kanekwa Zyambo; Dia Kumwenda; David Chama; Gabriel Muyinda; Michael Vinikoor; Samreen Ijaz; Richard Tedder; Ali Khalifa A Elmdaah; Meleri Jones; Clarence Chiluba; Victor Mudenda; Robert D Goldin; Graham Foster; Paul Kelly
Journal:  Trans R Soc Trop Med Hyg       Date:  2017-09-01       Impact factor: 2.184

4.  Transmission of Hepatitis B and D Viruses in an African Rural Community.

Authors:  Carlos Augusto Pinho-Nascimento; Martin W Bratschi; Rene Höfer; Caroline Cordeiro Soares; Louisa Warryn; Jūlija Pečerska; Jacques C Minyem; Izabel C N P Paixão; Marcia Terezinha Baroni de Moraes; Alphonse Um Boock; Christian Niel; Gerd Pluschke; Katharina Röltgen
Journal:  mSystems       Date:  2018-09-18       Impact factor: 6.496

5.  Phylodynamic and Phylogeographic Analysis of Hepatitis Delta Virus Genotype 3 Isolated in South America.

Authors:  Felipe Souza Nogueira-Lima; Luan Felipo Botelho-Souza; Tárcio Peixoto Roca; Alcione Oliveira Dos Santos; Suyane da Costa Oliveira; Jackson Alves da Silva Queiroz; Fabianne Araújo Gomes Dos Santos-Alves; Juan Miguel Villalobos Salcedo; Deusilene Souza Vieira
Journal:  Viruses       Date:  2019-10-29       Impact factor: 5.048

6.  Snake Deltavirus Utilizes Envelope Proteins of Different Viruses To Generate Infectious Particles.

Authors:  Leonora Szirovicza; Udo Hetzel; Anja Kipar; Luis Martinez-Sobrido; Olli Vapalahti; Jussi Hepojoki
Journal:  mBio       Date:  2020-03-17       Impact factor: 7.867

7.  Short '1.2× Genome' Infectious Clone Initiates Kolmiovirid Replication in Boa constrictor Cells.

Authors:  Leonora Szirovicza; Udo Hetzel; Anja Kipar; Jussi Hepojoki
Journal:  Viruses       Date:  2022-01-08       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.